載入...
Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt vs Deferred Laser Treatment: 3-year Randomized Trial Results
OBJECTIVE: To report 3-year follow-up within a previously reported randomized trial evaluating prompt versus deferred (for ≥24 weeks) focal/grid laser treatment in eyes treated with intravitreal 0.5-mg ranibizumab for diabetic macular edema (DME). DESIGN: Multicenter randomized clinical trial. PARTI...
Na minha lista:
| 格式: | Artigo |
|---|---|
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3490003/ https://ncbi.nlm.nih.gov/pubmed/22999634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2012.08.022 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|